Expression of Bcl-xs/l protein did not correlated with degree of myometrial invasion and pathological staging, but significantly correlated with clinical staging and lymph node metastasis of the sample (see Table 2). Here, BCL2L1 is linked to metastatic malignant neoplasm in the lymph nodes.